MUMBAI, March 14 (Reuters) - An Indian court on Monday
granted U.S. pharmaceuticals giant Pfizer Inc's PFE.N
PFIZ.NS India unit a stay on a government ban on its popular
cough syrup Corex, local television channels reported.
The ban on Pfizer's cough syrup was part of a wider notice
issued by the government over the weekend ordering prohibition
of the sale and manufacture of 344 combination drugs that a
panel of experts found posed a risk to humans. urn:newsml:reuters.com:*:nL3N16M1SX
The next hearing by the New Delhi High Court on Pfizer's
plea is slated for March 21, TV channels said.
(Reporting by Zeba Siddiqui in MUMBAI; Editing by Gopakumar
Warrier)
((swati.bhat@thomsonreuters.com; twitter.com/swatibhat22;
+91-22-61807353; Reuters Messaging:
swati.bhat.thomsonreuters.com@reuters.net))
Keywords: INDIA PFIZER/COURT